Sickle Cell Disease Diagnosis Market

Sickle Cell Disease Diagnosis Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

155

Base Year:

2022

Oct - 2023

Format:

Report Code:

VMR-VMR-2021-0209

Segments Covered

By Type Blood Transfusion , Bone Marrow Transplant , Pharmacotherapy
By End User Hospitals, Specialty Clinics , Others
By Region North America , Europe , Asia Pacific , Latin America , Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2022
Forecast Years:	2023 - 2030
Historical Years:	2017 - 2021
Revenue 2022:	USD 1.7 Billion
Revenue 2030:	USD 4.31 Billion
Revenue CAGR (2023 - 2030):	12.4%
Fastest Growing Region (2023 - 2030)	Asia Pacific
Largest Region (2022):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Sickle Cell Disease Diagnosis Market - Segment Analysis
1. Overview
2. Global Sickle Cell Disease Diagnosis Market, 2016 - 2028 (USD Million)
3. Global Sickle Cell Disease Diagnosis Market - by Type
  1. By Blood Transfusion
  2. By Bone Marrow Transplant
  3. By Pharmacotherapy
4. Global Sickle Cell Disease Diagnosis Market - by End User
  1. By Hospitals
  2. By Specialty Clinics
  3. By Others
5. Global Sickle Cell Disease Diagnosis Market - by Region
  1. By North America
  2. By Europe
  3. By Asia Pacific
  4. By Latin America
  5. By Middle East & Africa
6. Global Sickle Cell Disease Diagnosis Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
7. Market comparative analysis
North America Sickle Cell Disease Diagnosis Market - Segment Analysis
1. Overview
2. North America Sickle Cell Disease Diagnosis Market, 2016 - 2028 (USD Million)
3. North America Sickle Cell Disease Diagnosis Market, by Type
  1. By Blood Transfusion
  2. By Bone Marrow Transplant
  3. By Pharmacotherapy
4. North America Sickle Cell Disease Diagnosis Market, by End User
  1. By Hospitals
  2. By Specialty Clinics
  3. By Others
5. North America Sickle Cell Disease Diagnosis Market, by Region
  1. By North America
  2. By Europe
  3. By Asia Pacific
  4. By Latin America
  5. By Middle East & Africa
6. North America Sickle Cell Disease Diagnosis Market, by Country
  1. U.S.
    1. U.S. Sickle Cell Disease Diagnosis Market, By Type
      1. By Blood Transfusion
      2. By Bone Marrow Transplant
      3. By Pharmacotherapy
    2. U.S. Sickle Cell Disease Diagnosis Market, By End User
      1. By Hospitals
      2. By Specialty Clinics
      3. By Others
    3. U.S. Sickle Cell Disease Diagnosis Market, By Region
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Latin America
      5. By Middle East & Africa
  2. Canada
    1. Canada Sickle Cell Disease Diagnosis Market, By Type
      1. By Blood Transfusion
      2. By Bone Marrow Transplant
      3. By Pharmacotherapy
    2. Canada Sickle Cell Disease Diagnosis Market, By End User
      1. By Hospitals
      2. By Specialty Clinics
      3. By Others
    3. Canada Sickle Cell Disease Diagnosis Market, By Region
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Latin America
      5. By Middle East & Africa
  3. Mexico
    1. Mexico Sickle Cell Disease Diagnosis Market, By Type
      1. By Blood Transfusion
      2. By Bone Marrow Transplant
      3. By Pharmacotherapy
    2. Mexico Sickle Cell Disease Diagnosis Market, By End User
      1. By Hospitals
      2. By Specialty Clinics
      3. By Others
    3. Mexico Sickle Cell Disease Diagnosis Market, By Region
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Latin America
      5. By Middle East & Africa
Europe Sickle Cell Disease Diagnosis Market - Segment Analysis
1. Overview
2. Europe Sickle Cell Disease Diagnosis Market, 2016 - 2028 (USD Million)
3. Europe Sickle Cell Disease Diagnosis Market, by Type
  1. By Blood Transfusion
  2. By Bone Marrow Transplant
  3. By Pharmacotherapy
4. Europe Sickle Cell Disease Diagnosis Market, by End User
  1. By Hospitals
  2. By Specialty Clinics
  3. By Others
5. Europe Sickle Cell Disease Diagnosis Market, by Region
  1. By North America
  2. By Europe
  3. By Asia Pacific
  4. By Latin America
  5. By Middle East & Africa
6. Europe Sickle Cell Disease Diagnosis Market, by Country
  1. Germany
    1. Germany Sickle Cell Disease Diagnosis Market, By Type
      1. By Blood Transfusion
      2. By Bone Marrow Transplant
      3. By Pharmacotherapy
    2. Germany Sickle Cell Disease Diagnosis Market, By End User
      1. By Hospitals
      2. By Specialty Clinics
      3. By Others
    3. Germany Sickle Cell Disease Diagnosis Market, By Region
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Latin America
      5. By Middle East & Africa
  2. UK
    1. UK Market, By Type
      1. By Blood Transfusion
      2. By Bone Marrow Transplant
      3. By Pharmacotherapy
    2. UK Market, By End User
      1. By Hospitals
      2. By Specialty Clinics
      3. By Others
    3. UK Market, By Region
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Latin America
      5. By Middle East & Africa
  3. France
    1. France Sickle Cell Disease Diagnosis Market, By Type
      1. By Blood Transfusion
      2. By Bone Marrow Transplant
      3. By Pharmacotherapy
    2. France Sickle Cell Disease Diagnosis Market, By End User
      1. By Hospitals
      2. By Specialty Clinics
      3. By Others
    3. France Sickle Cell Disease Diagnosis Market, By Region
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Latin America
      5. By Middle East & Africa
  4. Spain
    1. Spain Sickle Cell Disease Diagnosis Market, By Type
      1. By Blood Transfusion
      2. By Bone Marrow Transplant
      3. By Pharmacotherapy
    2. Spain Sickle Cell Disease Diagnosis Market, By End User
      1. By Hospitals
      2. By Specialty Clinics
      3. By Others
    3. Spain Sickle Cell Disease Diagnosis Market, By Region
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Latin America
      5. By Middle East & Africa
  5. Italy
    1. Italy Sickle Cell Disease Diagnosis Market, By Type
      1. By Blood Transfusion
      2. By Bone Marrow Transplant
      3. By Pharmacotherapy
    2. Italy Sickle Cell Disease Diagnosis Market, By End User
      1. By Hospitals
      2. By Specialty Clinics
      3. By Others
    3. Italy Sickle Cell Disease Diagnosis Market, By Region
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Latin America
      5. By Middle East & Africa
  6. BENELUX
    1. BENELUX Sickle Cell Disease Diagnosis Market, By Type
      1. By Blood Transfusion
      2. By Bone Marrow Transplant
      3. By Pharmacotherapy
    2. BENELUX Sickle Cell Disease Diagnosis Market, By End User
      1. By Hospitals
      2. By Specialty Clinics
      3. By Others
    3. BENELUX Sickle Cell Disease Diagnosis Market, By Region
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Latin America
      5. By Middle East & Africa
  7. Rest of Europe
    1. Rest Of Europe Sickle Cell Disease Diagnosis Market, By Type
      1. By Blood Transfusion
      2. By Bone Marrow Transplant
      3. By Pharmacotherapy
    2. Rest Of Europe Sickle Cell Disease Diagnosis Market, By End User
      1. By Hospitals
      2. By Specialty Clinics
      3. By Others
    3. Rest Of Europe Sickle Cell Disease Diagnosis Market, By Region
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Latin America
      5. By Middle East & Africa
Asia Pacific Sickle Cell Disease Diagnosis Market - Segment Analysis
1. Overview
2. Asia Pacific Sickle Cell Disease Diagnosis Market, 2016 - 2028 (USD Million)
3. Asia Pacific Sickle Cell Disease Diagnosis Market, by Type
  1. By Blood Transfusion
  2. By Bone Marrow Transplant
  3. By Pharmacotherapy
4. Asia Pacific Sickle Cell Disease Diagnosis Market, by End User
  1. By Hospitals
  2. By Specialty Clinics
  3. By Others
5. Asia Pacific Sickle Cell Disease Diagnosis Market, by Region
  1. By North America
  2. By Europe
  3. By Asia Pacific
  4. By Latin America
  5. By Middle East & Africa
6. Asia Pacific Sickle Cell Disease Diagnosis Market, by Country
  1. China
    1. China Sickle Cell Disease Diagnosis Market, By Type
      1. By Blood Transfusion
      2. By Bone Marrow Transplant
      3. By Pharmacotherapy
    2. China Sickle Cell Disease Diagnosis Market, By End User
      1. By Hospitals
      2. By Specialty Clinics
      3. By Others
    3. China Sickle Cell Disease Diagnosis Market, By Region
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Latin America
      5. By Middle East & Africa
  2. Japan
    1. Japan Sickle Cell Disease Diagnosis Market, By Type
      1. By Blood Transfusion
      2. By Bone Marrow Transplant
      3. By Pharmacotherapy
    2. Japan Sickle Cell Disease Diagnosis Market, By End User
      1. By Hospitals
      2. By Specialty Clinics
      3. By Others
    3. Japan Sickle Cell Disease Diagnosis Market, By Region
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Latin America
      5. By Middle East & Africa
  3. India
    1. India Sickle Cell Disease Diagnosis Market, By Type
      1. By Blood Transfusion
      2. By Bone Marrow Transplant
      3. By Pharmacotherapy
    2. India Sickle Cell Disease Diagnosis Market, By End User
      1. By Hospitals
      2. By Specialty Clinics
      3. By Others
    3. India Sickle Cell Disease Diagnosis Market, By Region
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Latin America
      5. By Middle East & Africa
  4. South Korea
    1. South Korea Sickle Cell Disease Diagnosis Market, By Type
      1. By Blood Transfusion
      2. By Bone Marrow Transplant
      3. By Pharmacotherapy
    2. South Korea Sickle Cell Disease Diagnosis Market, By End User
      1. By Hospitals
      2. By Specialty Clinics
      3. By Others
    3. South Korea Sickle Cell Disease Diagnosis Market, By Region
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Latin America
      5. By Middle East & Africa
  5. South East Asia
    1. South East Asia Sickle Cell Disease Diagnosis Market, By Type
      1. By Blood Transfusion
      2. By Bone Marrow Transplant
      3. By Pharmacotherapy
    2. South East Asia Sickle Cell Disease Diagnosis Market, By End User
      1. By Hospitals
      2. By Specialty Clinics
      3. By Others
    3. South East Asia Sickle Cell Disease Diagnosis Market, By Region
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Latin America
      5. By Middle East & Africa
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Sickle Cell Disease Diagnosis Market, By Type
      1. By Blood Transfusion
      2. By Bone Marrow Transplant
      3. By Pharmacotherapy
    2. Rest of Asia Pacific Sickle Cell Disease Diagnosis Market, By End User
      1. By Hospitals
      2. By Specialty Clinics
      3. By Others
    3. Rest of Asia Pacific Sickle Cell Disease Diagnosis Market, By Region
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Latin America
      5. By Middle East & Africa
Latin America Sickle Cell Disease Diagnosis Market - Segment Analysis
1. Overview
2. Latin America Sickle Cell Disease Diagnosis Market, 2016 - 2028 (USD Million)
3. Latin America Sickle Cell Disease Diagnosis Market, by Type
  1. By Blood Transfusion
  2. By Bone Marrow Transplant
  3. By Pharmacotherapy
4. Latin America Sickle Cell Disease Diagnosis Market, by End User
  1. By Hospitals
  2. By Specialty Clinics
  3. By Others
5. Latin America Sickle Cell Disease Diagnosis Market, by Region
  1. By North America
  2. By Europe
  3. By Asia Pacific
  4. By Latin America
  5. By Middle East & Africa
6. Latin America Sickle Cell Disease Diagnosis Market, by Country
  1. Brazil
    1. Brazil Sickle Cell Disease Diagnosis Market, By Type
      1. By Blood Transfusion
      2. By Bone Marrow Transplant
      3. By Pharmacotherapy
    2. Brazil Sickle Cell Disease Diagnosis Market, By End User
      1. By Hospitals
      2. By Specialty Clinics
      3. By Others
    3. Brazil Sickle Cell Disease Diagnosis Market, By Region
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Latin America
      5. By Middle East & Africa
  2. Argentina
    1. Argentina Sickle Cell Disease Diagnosis Market, By Type
      1. By Blood Transfusion
      2. By Bone Marrow Transplant
      3. By Pharmacotherapy
    2. Argentina Sickle Cell Disease Diagnosis Market, By End User
      1. By Hospitals
      2. By Specialty Clinics
      3. By Others
    3. Argentina Sickle Cell Disease Diagnosis Market, By Region
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Latin America
      5. By Middle East & Africa
  3. Rest of Latin America
    1. Rest of Latin America Sickle Cell Disease Diagnosis Market, By Type
      1. By Blood Transfusion
      2. By Bone Marrow Transplant
      3. By Pharmacotherapy
    2. Rest of Latin America Sickle Cell Disease Diagnosis Market, By End User
      1. By Hospitals
      2. By Specialty Clinics
      3. By Others
    3. Rest of Latin America Sickle Cell Disease Diagnosis Market, By Region
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Latin America
      5. By Middle East & Africa
Middle East & Africa Sickle Cell Disease Diagnosis Market - Segment Analysis
1. Overview
2. Middle East & Africa Sickle Cell Disease Diagnosis Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Sickle Cell Disease Diagnosis Market, by Type
  1. By Blood Transfusion
  2. By Bone Marrow Transplant
  3. By Pharmacotherapy
4. Middle East & Africa Sickle Cell Disease Diagnosis Market, by End User
  1. By Hospitals
  2. By Specialty Clinics
  3. By Others
5. Middle East & Africa Sickle Cell Disease Diagnosis Market, by Region
  1. By North America
  2. By Europe
  3. By Asia Pacific
  4. By Latin America
  5. By Middle East & Africa
6. Middle East & Africa Sickle Cell Disease Diagnosis Market, by Country
  1. GCC Countries
    1. GCC Countries Sickle Cell Disease Diagnosis Market, By Type
      1. By Blood Transfusion
      2. By Bone Marrow Transplant
      3. By Pharmacotherapy
    2. GCC Countries Sickle Cell Disease Diagnosis Market, By End User
      1. By Hospitals
      2. By Specialty Clinics
      3. By Others
    3. GCC Countries Sickle Cell Disease Diagnosis Market, By Region
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Latin America
      5. By Middle East & Africa
  2. South Africa
    1. South Africa Sickle Cell Disease Diagnosis Market, By Type
      1. By Blood Transfusion
      2. By Bone Marrow Transplant
      3. By Pharmacotherapy
    2. South Africa Sickle Cell Disease Diagnosis Market, By End User
      1. By Hospitals
      2. By Specialty Clinics
      3. By Others
    3. South Africa Sickle Cell Disease Diagnosis Market, By Region
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Latin America
      5. By Middle East & Africa
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Sickle Cell Disease Diagnosis Market, By Type
      1. By Blood Transfusion
      2. By Bone Marrow Transplant
      3. By Pharmacotherapy
    2. Rest of Middle East & Africa Sickle Cell Disease Diagnosis Market, By End User
      1. By Hospitals
      2. By Specialty Clinics
      3. By Others
    3. Rest of Middle East & Africa Sickle Cell Disease Diagnosis Market, By Region
      1. By North America
      2. By Europe
      3. By Asia Pacific
      4. By Latin America
      5. By Middle East & Africa
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Novartis AG
2. Holdings
3. Halcyon Biomedical Incorporated
4. Silver Lake Research Corporation
5. Quest Diagnostics
6. Emmaus Medical Inc.
7. Addmedica
8. Medunik USA Inc.
9. STRECK INC.
10. Bio-Rad Laboratories Inc.
11. Bristol-Myers Squibb Company
12. Agios Pharmaceuticals Inc.
13. Daktari Diagnostics
14. Biomedomics Inc.
15. Laboratory Corporation of America
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

FAQ

Frequently Asked Question

What is the global demand for Sickle Cell Disease Diagnosis in terms of revenue?

The global Sickle Cell Disease Diagnosis valued at USD 1.7 Billion in 2022 and is expected to reach USD 4.31 Billion in 2030 growing at a CAGR of 12.4%.

Which are the prominent players in the market?

The prominent players in the market are Novartis AG, Holdings, Halcyon Biomedical Incorporated, Silver Lake Research Corporation, Quest Diagnostics, Emmaus Medical Inc., Addmedica, Medunik USA Inc., STRECK INC., Bio-Rad Laboratories Inc., Bristol-Myers Squibb Company, Agios Pharmaceuticals, Inc., Daktari Diagnostics, Biomedomics Inc., Laboratory Corporation of America.

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 12.4% between 2023 and 2030.

What are the driving factors fueling the growth of the market.

The driving factors of the Sickle Cell Disease Diagnosis include
- Growing awareness and emphasis on early diagnosis

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Sickle Cell Disease Diagnosis in 2022.

Sickle Cell Disease Diagnosis Market

Sickle Cell Disease Diagnosis Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Sickle Cell Disease Diagnosis in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Quick Links

For Buying Inquiry

Sickle Cell Disease Diagnosis Market

Sickle Cell Disease Diagnosis Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Sickle Cell Disease Diagnosis in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Sickle Cell Disease Diagnosis Market

Vantage Point Interactive Dashboard